Telix buys ITM in bid to create a ‘radiopharmaceutical powerhouse’
Worth $1.65 billion up front, the deal combines two large pipelines and manufacturing networks, helping Telix potentially “corner the industry” for radiopharmaceuticals, one analyst wrote.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.